跳至主要内容
临床试验/ITMCTR2000003772
ITMCTR2000003772招募中1 期

A randomized controlled clinical trial of Qingdai(indigo naturalis) in the treatment of mild to moderate active ulcerative colitis

Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) it accords with the diagnostic standard of western medicine for ulcerative colitis.
  • (2) the selected patients were mild to moderate ulcerative colitis (total Mayo score = 310).
  • (3) 18-65 years old; regardless of sex.
  • (4) agree to participate in this study and sign the informed letter at the same time.

排除标准

  • (1) Patients with infectious colitis such as bacillary dysentery, amoebic dysentery, chronic schistosomiasis, intestinal tuberculosis, Crohn's disease, ischemic enteritis and radiation enteritis.
  • (2) Patients with serious complications such as local stenosis, intestinal obstruction, intestinal perforation, toxic colonic dilatation, massive hemorrhage, colon cancer, rectal cancer.
  • (3) Patients with other primary and secondary infectious diseases, such as cholecystitis, pneumonia, etc.
  • (4) Patients with serious diseases of cardiovascular, hepatobiliary, lung, kidney and blood system.
  • (5) Women during pregnancy and lactation.
  • (6) Patients with disabilities prescribed by law (blindness, deafness, mute, mental retardation, physical disability).
  • (7) Patients with severe ulcerative colitis (Mayo=11~12 score); or patients with complications.

研究者

发起方
Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine

相似试验

A randomized controlled clinical trial of... | 临床试验